APO Research
Talk to an analyst

APO RESEARCH · REPORT

Organ Preservation Solutions

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Organ Preservation Solutions Market Outlook and Growth Opportunities 2026

19 December 2025196 pages

Choose your research edition.

Industry ResearchOrgan Preservation Solutions Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Organ Preservation Solutions Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Organ Preservation Solutions Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Organ Preservation Solutions Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Organ Preservation Solutions Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Organ Preservation Solutions market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Organ Preservation Solutions is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Organ Preservation Solutions is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Organ Preservation Solutions is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Organ Preservation Solutions market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Organ Preservation Solutions market include 21st Century Medicine, BioLife Solutions, Inc., BioTime, Inc., Bristol-Myers Squibb, Claris Lifesciences Limited, CryoLife, Inc., Dr. Franz Köhler Chemie, Lifeline Scientific and Teva Pharmaceutical Industries Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Organ Preservation Solutions market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Organ Preservation Solutions and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Organ Preservation Solutions revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Organ Preservation Solutions market.

Organ Preservation Solutions Segment by Company

21st Century Medicine

BioLife Solutions, Inc.

BioTime, Inc.

Bristol-Myers Squibb

Claris Lifesciences Limited

CryoLife, Inc.

Dr. Franz Köhler Chemie

Lifeline Scientific

Teva Pharmaceutical Industries Ltd.

ToleroTech, Inc

XVIVO Perfusion AB

Organ Preservation Solutions Segment by Type

Viaspan

Custodial

siRNA Transplant Solutions

Others

Organ Preservation Solutions Segment by Application

Hypothermic Perfusion Preservation (HPP)

Static Cold Storage (SCS)

Others

Organ Preservation Solutions Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Organ Preservation Solutions status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Organ Preservation Solutions key companies, revenue, market share, and recent developments.

3. To split the Organ Preservation Solutions breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Organ Preservation Solutions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Organ Preservation Solutions significant trends, drivers, influence factors in global and regions.

6. To analyze Organ Preservation Solutions competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Organ Preservation Solutions market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Organ Preservation Solutions and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Organ Preservation Solutions.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Organ Preservation Solutions industry.

Chapter 3: Detailed analysis of Organ Preservation Solutions company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Organ Preservation Solutions in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Organ Preservation Solutions in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Organ Preservation Solutions Industry Trends Table 2. Organ Preservation Solutions Industry Drivers Table 3. Organ Preservation Solutions Industry Opportunities and Challenges Table 4. Organ Preservation Solutions Industry Restraints Table 5. Global Organ Preservation Solutions Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Organ Preservation Solutions Revenue Share by Company (2021-2026) Table 7. Global Organ Preservation Solutions Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Organ Preservation Solutions Key Company Manufacturing Base & Headquarters Table 9. Global Organ Preservation Solutions Company, Product Type & Application Table 10. Global Organ Preservation Solutions Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Organ Preservation Solutions by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Viaspan Table 15. Significant Companies of Custodial Table 16. Significant Companies of siRNA Transplant Solutions Table 17. Significant Companies of Others Table 18. Global Organ Preservation Solutions Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Organ Preservation Solutions Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global Organ Preservation Solutions Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global Organ Preservation Solutions Sales Value Share by Type (2021-2026) Table 22. Global Organ Preservation Solutions Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Hypothermic Perfusion Preservation (HPP) Table 24. Significant Companies of Static Cold Storage (SCS) Table 25. Significant Companies of Others Table 26. Global Organ Preservation Solutions Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Organ Preservation Solutions Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global Organ Preservation Solutions Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global Organ Preservation Solutions Sales Value Share by Application (2021-2026) Table 30. Global Organ Preservation Solutions Sales Value Share by Application (2027-2032) Table 31. Global Organ Preservation Solutions Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Organ Preservation Solutions Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global Organ Preservation Solutions Sales Value Share by Region (2021-2026) Table 34. Global Organ Preservation Solutions Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global Organ Preservation Solutions Sales Value Share by Region (2027-2032) Table 36. Global Organ Preservation Solutions Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Organ Preservation Solutions Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global Organ Preservation Solutions Sales Value Market Share by Country (2021-2026) Table 39. Global Organ Preservation Solutions Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global Organ Preservation Solutions Sales Value Market Share by Country (2027-2032) Table 41. 21st Century Medicine Company Information Table 42. 21st Century Medicine Business Overview Table 43. 21st Century Medicine Organ Preservation Solutions Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. 21st Century Medicine Organ Preservation Solutions Product Portfolio Table 45. 21st Century Medicine Recent Development Table 46. BioLife Solutions, Inc. Company Information Table 47. BioLife Solutions, Inc. Business Overview Table 48. BioLife Solutions, Inc. Organ Preservation Solutions Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. BioLife Solutions, Inc. Organ Preservation Solutions Product Portfolio Table 50. BioLife Solutions, Inc. Recent Development Table 51. BioTime, Inc. Company Information Table 52. BioTime, Inc. Business Overview Table 53. BioTime, Inc. Organ Preservation Solutions Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. BioTime, Inc. Organ Preservation Solutions Product Portfolio Table 55. BioTime, Inc. Recent Development Table 56. Bristol-Myers Squibb Company Information Table 57. Bristol-Myers Squibb Business Overview Table 58. Bristol-Myers Squibb Organ Preservation Solutions Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. Bristol-Myers Squibb Organ Preservation Solutions Product Portfolio Table 60. Bristol-Myers Squibb Recent Development Table 61. Claris Lifesciences Limited Company Information Table 62. Claris Lifesciences Limited Business Overview Table 63. Claris Lifesciences Limited Organ Preservation Solutions Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. Claris Lifesciences Limited Organ Preservation Solutions Product Portfolio Table 65. Claris Lifesciences Limited Recent Development Table 66. CryoLife, Inc. Company Information Table 67. CryoLife, Inc. Business Overview Table 68. CryoLife, Inc. Organ Preservation Solutions Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. CryoLife, Inc. Organ Preservation Solutions Product Portfolio Table 70. CryoLife, Inc. Recent Development Table 71. Dr. Franz Köhler Chemie Company Information Table 72. Dr. Franz Köhler Chemie Business Overview Table 73. Dr. Franz Köhler Chemie Organ Preservation Solutions Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Dr. Franz Köhler Chemie Organ Preservation Solutions Product Portfolio Table 75. Dr. Franz Köhler Chemie Recent Development Table 76. Lifeline Scientific Company Information Table 77. Lifeline Scientific Business Overview Table 78. Lifeline Scientific Organ Preservation Solutions Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Lifeline Scientific Organ Preservation Solutions Product Portfolio Table 80. Lifeline Scientific Recent Development Table 81. Teva Pharmaceutical Industries Ltd. Company Information Table 82. Teva Pharmaceutical Industries Ltd. Business Overview Table 83. Teva Pharmaceutical Industries Ltd. Organ Preservation Solutions Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Teva Pharmaceutical Industries Ltd. Organ Preservation Solutions Product Portfolio Table 85. Teva Pharmaceutical Industries Ltd. Recent Development Table 86. ToleroTech, Inc Company Information Table 87. ToleroTech, Inc Business Overview Table 88. ToleroTech, Inc Organ Preservation Solutions Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. ToleroTech, Inc Organ Preservation Solutions Product Portfolio Table 90. ToleroTech, Inc Recent Development Table 91. XVIVO Perfusion AB Company Information Table 92. XVIVO Perfusion AB Business Overview Table 93. XVIVO Perfusion AB Organ Preservation Solutions Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. XVIVO Perfusion AB Organ Preservation Solutions Product Portfolio Table 95. XVIVO Perfusion AB Recent Development Table 96. Research Programs/Design for This Report Table 97. Authors List of This Report Table 98. Secondary Sources Table 99. Primary Sources List of Figures Figure 1. Organ Preservation Solutions Product Image Figure 2. Global Organ Preservation Solutions Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Organ Preservation Solutions Market Size (2021-2032) & (US$ Million) Figure 4. Global Organ Preservation Solutions Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Viaspan Image Figure 8. Custodial Image Figure 9. siRNA Transplant Solutions Image Figure 10. Others Image Figure 11. Global Organ Preservation Solutions Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Organ Preservation Solutions Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global Organ Preservation Solutions Sales Value Share by Type (2021-2032) Figure 14. Hypothermic Perfusion Preservation (HPP) Image Figure 15. Static Cold Storage (SCS) Image Figure 16. Others Image Figure 17. Global Organ Preservation Solutions Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Organ Preservation Solutions Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Organ Preservation Solutions Sales Value Share by Application (2021-2032) Figure 20. Global Organ Preservation Solutions Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global Organ Preservation Solutions Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America Organ Preservation Solutions Sales Value (2021-2032) & (US$ Million) Figure 23. North America Organ Preservation Solutions Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe Organ Preservation Solutions Sales Value (2021-2032) & (US$ Million) Figure 25. Europe Organ Preservation Solutions Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific Organ Preservation Solutions Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific Organ Preservation Solutions Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America Organ Preservation Solutions Sales Value (2021-2032) & (US$ Million) Figure 29. South America Organ Preservation Solutions Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa Organ Preservation Solutions Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa Organ Preservation Solutions Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA Organ Preservation Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA Organ Preservation Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA Organ Preservation Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada Organ Preservation Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada Organ Preservation Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada Organ Preservation Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico Organ Preservation Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico Organ Preservation Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico Organ Preservation Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany Organ Preservation Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany Organ Preservation Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany Organ Preservation Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France Organ Preservation Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France Organ Preservation Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France Organ Preservation Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. Organ Preservation Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. Organ Preservation Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. Organ Preservation Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy Organ Preservation Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy Organ Preservation Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy Organ Preservation Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain Organ Preservation Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain Organ Preservation Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain Organ Preservation Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia Organ Preservation Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia Organ Preservation Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia Organ Preservation Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands Organ Preservation Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands Organ Preservation Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands Organ Preservation Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries Organ Preservation Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries Organ Preservation Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries Organ Preservation Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China Organ Preservation Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China Organ Preservation Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China Organ Preservation Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan Organ Preservation Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan Organ Preservation Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan Organ Preservation Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea Organ Preservation Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea Organ Preservation Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea Organ Preservation Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India Organ Preservation Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India Organ Preservation Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India Organ Preservation Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia Organ Preservation Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia Organ Preservation Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia Organ Preservation Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia Organ Preservation Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia Organ Preservation Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia Organ Preservation Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil Organ Preservation Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil Organ Preservation Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil Organ Preservation Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina Organ Preservation Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina Organ Preservation Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina Organ Preservation Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile Organ Preservation Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile Organ Preservation Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile Organ Preservation Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia Organ Preservation Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia Organ Preservation Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia Organ Preservation Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru Organ Preservation Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru Organ Preservation Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru Organ Preservation Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Organ Preservation Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia Organ Preservation Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Organ Preservation Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel Organ Preservation Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel Organ Preservation Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel Organ Preservation Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE Organ Preservation Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE Organ Preservation Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE Organ Preservation Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey Organ Preservation Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey Organ Preservation Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey Organ Preservation Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran Organ Preservation Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran Organ Preservation Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran Organ Preservation Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt Organ Preservation Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt Organ Preservation Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt Organ Preservation Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • Viaspan
  • Custodial
  • siRNA Transplant Solutions
  • Others
Applications
  • Hypothermic Perfusion Preservation (HPP)
  • Static Cold Storage (SCS)
  • Others
Companies covered
  • 21st Century Medicine
  • BioLife Solutions, Inc.
  • BioTime, Inc.
  • Bristol-Myers Squibb
  • Claris Lifesciences Limited
  • CryoLife, Inc.
  • Dr. Franz Köhler Chemie
  • Lifeline Scientific
  • Teva Pharmaceutical Industries Ltd.
  • ToleroTech, Inc
  • XVIVO Perfusion AB

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Organ Preservation Solutions Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Organ Preservation Solutions Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Organ Preservation Solutions Market Dynamics
  1. 2.1 Organ Preservation Solutions Industry Trends
  2. 2.2 Organ Preservation Solutions Industry Drivers
  3. 2.3 Organ Preservation Solutions Industry Opportunities and Challenges
  4. 2.4 Organ Preservation Solutions Industry Restraints
3 Organ Preservation Solutions Market by Company
  1. 3.1 Global Organ Preservation Solutions Company Revenue Ranking in 2025
  2. 3.2 Global Organ Preservation Solutions Revenue by Company (2021-2026)
  3. 3.3 Global Organ Preservation Solutions Company Ranking (2024-2026)
  4. 3.4 Global Organ Preservation Solutions Company Manufacturing Base and Headquarters
  5. 3.5 Global Organ Preservation Solutions Company Product Type and Application
  6. 3.6 Global Organ Preservation Solutions Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Organ Preservation Solutions Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Organ Preservation Solutions Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Organ Preservation Solutions Market by Type
  1. 4.1 Organ Preservation Solutions Type Introduction
  2. 4.1.1 Viaspan
  3. 4.1.2 Custodial
  4. 4.1.3 siRNA Transplant Solutions
  5. 4.1.4 Others
  6. 4.2 Global Organ Preservation Solutions Sales Value by Type
  7. 4.2.1 Global Organ Preservation Solutions Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Organ Preservation Solutions Sales Value by Type (2021-2032)
  9. 4.2.3 Global Organ Preservation Solutions Sales Value Share by Type (2021-2032)
5 Organ Preservation Solutions Market by Application
  1. 5.1 Organ Preservation Solutions Application Introduction
  2. 5.1.1 Hypothermic Perfusion Preservation (HPP)
  3. 5.1.2 Static Cold Storage (SCS)
  4. 5.1.3 Others
  5. 5.2 Global Organ Preservation Solutions Sales Value by Application
  6. 5.2.1 Global Organ Preservation Solutions Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Organ Preservation Solutions Sales Value by Application (2021-2032)
  8. 5.2.3 Global Organ Preservation Solutions Sales Value Share by Application (2021-2032)
6 Organ Preservation Solutions Regional Value Analysis
  1. 6.1 Global Organ Preservation Solutions Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Organ Preservation Solutions Sales Value by Region (2021-2032)
  3. 6.2.1 Global Organ Preservation Solutions Sales Value by Region: 2021-2026
  4. 6.2.2 Global Organ Preservation Solutions Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Organ Preservation Solutions Sales Value (2021-2032)
  7. 6.3.2 North America Organ Preservation Solutions Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Organ Preservation Solutions Sales Value (2021-2032)
  10. 6.4.2 Europe Organ Preservation Solutions Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Organ Preservation Solutions Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Organ Preservation Solutions Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Organ Preservation Solutions Sales Value (2021-2032)
  16. 6.6.2 South America Organ Preservation Solutions Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Organ Preservation Solutions Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Organ Preservation Solutions Sales Value Share by Country, 2025 VS 2032
7 Organ Preservation Solutions Country-level Value Analysis
  1. 7.1 Global Organ Preservation Solutions Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Organ Preservation Solutions Sales Value by Country (2021-2032)
  3. 7.2.1 Global Organ Preservation Solutions Sales Value by Country (2021-2026)
  4. 7.2.2 Global Organ Preservation Solutions Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Organ Preservation Solutions Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Organ Preservation Solutions Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Organ Preservation Solutions Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Organ Preservation Solutions Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Organ Preservation Solutions Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Organ Preservation Solutions Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Organ Preservation Solutions Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Organ Preservation Solutions Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Organ Preservation Solutions Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Organ Preservation Solutions Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Organ Preservation Solutions Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Organ Preservation Solutions Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Organ Preservation Solutions Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Organ Preservation Solutions Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Organ Preservation Solutions Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Organ Preservation Solutions Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Organ Preservation Solutions Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Organ Preservation Solutions Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Organ Preservation Solutions Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Organ Preservation Solutions Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Organ Preservation Solutions Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Organ Preservation Solutions Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Organ Preservation Solutions Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Organ Preservation Solutions Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Organ Preservation Solutions Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Organ Preservation Solutions Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Organ Preservation Solutions Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Organ Preservation Solutions Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Organ Preservation Solutions Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Organ Preservation Solutions Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Organ Preservation Solutions Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Organ Preservation Solutions Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Organ Preservation Solutions Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Organ Preservation Solutions Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Organ Preservation Solutions Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Organ Preservation Solutions Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Organ Preservation Solutions Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Organ Preservation Solutions Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Organ Preservation Solutions Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Organ Preservation Solutions Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Organ Preservation Solutions Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Organ Preservation Solutions Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Organ Preservation Solutions Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Organ Preservation Solutions Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Organ Preservation Solutions Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Organ Preservation Solutions Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Organ Preservation Solutions Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Organ Preservation Solutions Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Organ Preservation Solutions Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Organ Preservation Solutions Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Organ Preservation Solutions Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Organ Preservation Solutions Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Organ Preservation Solutions Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Organ Preservation Solutions Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Organ Preservation Solutions Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Organ Preservation Solutions Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Organ Preservation Solutions Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Organ Preservation Solutions Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Organ Preservation Solutions Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Organ Preservation Solutions Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Organ Preservation Solutions Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Organ Preservation Solutions Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Organ Preservation Solutions Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Organ Preservation Solutions Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Organ Preservation Solutions Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Organ Preservation Solutions Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Organ Preservation Solutions Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Organ Preservation Solutions Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Organ Preservation Solutions Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Organ Preservation Solutions Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Organ Preservation Solutions Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Organ Preservation Solutions Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Organ Preservation Solutions Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Organ Preservation Solutions Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Organ Preservation Solutions Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Organ Preservation Solutions Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Organ Preservation Solutions Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Organ Preservation Solutions Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Organ Preservation Solutions Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Organ Preservation Solutions Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Organ Preservation Solutions Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Organ Preservation Solutions Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Organ Preservation Solutions Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Organ Preservation Solutions Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 21st Century Medicine
  2. 8.1.1 21st Century Medicine Company Information
  3. 8.1.2 21st Century Medicine Business Overview
  4. 8.1.3 21st Century Medicine Organ Preservation Solutions Revenue and Gross Margin (2021-2026)
  5. 8.1.4 21st Century Medicine Organ Preservation Solutions Product Portfolio
  6. 8.1.5 21st Century Medicine Recent Developments
  7. 8.2 BioLife Solutions, Inc.
  8. 8.2.1 BioLife Solutions, Inc. Company Information
  9. 8.2.2 BioLife Solutions, Inc. Business Overview
  10. 8.2.3 BioLife Solutions, Inc. Organ Preservation Solutions Revenue and Gross Margin (2021-2026)
  11. 8.2.4 BioLife Solutions, Inc. Organ Preservation Solutions Product Portfolio
  12. 8.2.5 BioLife Solutions, Inc. Recent Developments
  13. 8.3 BioTime, Inc.
  14. 8.3.1 BioTime, Inc. Company Information
  15. 8.3.2 BioTime, Inc. Business Overview
  16. 8.3.3 BioTime, Inc. Organ Preservation Solutions Revenue and Gross Margin (2021-2026)
  17. 8.3.4 BioTime, Inc. Organ Preservation Solutions Product Portfolio
  18. 8.3.5 BioTime, Inc. Recent Developments
  19. 8.4 Bristol-Myers Squibb
  20. 8.4.1 Bristol-Myers Squibb Company Information
  21. 8.4.2 Bristol-Myers Squibb Business Overview
  22. 8.4.3 Bristol-Myers Squibb Organ Preservation Solutions Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Bristol-Myers Squibb Organ Preservation Solutions Product Portfolio
  24. 8.4.5 Bristol-Myers Squibb Recent Developments
  25. 8.5 Claris Lifesciences Limited
  26. 8.5.1 Claris Lifesciences Limited Company Information
  27. 8.5.2 Claris Lifesciences Limited Business Overview
  28. 8.5.3 Claris Lifesciences Limited Organ Preservation Solutions Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Claris Lifesciences Limited Organ Preservation Solutions Product Portfolio
  30. 8.5.5 Claris Lifesciences Limited Recent Developments
  31. 8.6 CryoLife, Inc.
  32. 8.6.1 CryoLife, Inc. Company Information
  33. 8.6.2 CryoLife, Inc. Business Overview
  34. 8.6.3 CryoLife, Inc. Organ Preservation Solutions Revenue and Gross Margin (2021-2026)
  35. 8.6.4 CryoLife, Inc. Organ Preservation Solutions Product Portfolio
  36. 8.6.5 CryoLife, Inc. Recent Developments
  37. 8.7 Dr. Franz Köhler Chemie
  38. 8.7.1 Dr. Franz Köhler Chemie Company Information
  39. 8.7.2 Dr. Franz Köhler Chemie Business Overview
  40. 8.7.3 Dr. Franz Köhler Chemie Organ Preservation Solutions Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Dr. Franz Köhler Chemie Organ Preservation Solutions Product Portfolio
  42. 8.7.5 Dr. Franz Köhler Chemie Recent Developments
  43. 8.8 Lifeline Scientific
  44. 8.8.1 Lifeline Scientific Company Information
  45. 8.8.2 Lifeline Scientific Business Overview
  46. 8.8.3 Lifeline Scientific Organ Preservation Solutions Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Lifeline Scientific Organ Preservation Solutions Product Portfolio
  48. 8.8.5 Lifeline Scientific Recent Developments
  49. 8.9 Teva Pharmaceutical Industries Ltd.
  50. 8.9.1 Teva Pharmaceutical Industries Ltd. Company Information
  51. 8.9.2 Teva Pharmaceutical Industries Ltd. Business Overview
  52. 8.9.3 Teva Pharmaceutical Industries Ltd. Organ Preservation Solutions Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Teva Pharmaceutical Industries Ltd. Organ Preservation Solutions Product Portfolio
  54. 8.9.5 Teva Pharmaceutical Industries Ltd. Recent Developments
  55. 8.10 ToleroTech, Inc
  56. 8.10.1 ToleroTech, Inc Company Information
  57. 8.10.2 ToleroTech, Inc Business Overview
  58. 8.10.3 ToleroTech, Inc Organ Preservation Solutions Revenue and Gross Margin (2021-2026)
  59. 8.10.4 ToleroTech, Inc Organ Preservation Solutions Product Portfolio
  60. 8.10.5 ToleroTech, Inc Recent Developments
  61. 8.11 XVIVO Perfusion AB
  62. 8.11.1 XVIVO Perfusion AB Company Information
  63. 8.11.2 XVIVO Perfusion AB Business Overview
  64. 8.11.3 XVIVO Perfusion AB Organ Preservation Solutions Revenue and Gross Margin (2021-2026)
  65. 8.11.4 XVIVO Perfusion AB Organ Preservation Solutions Product Portfolio
  66. 8.11.5 XVIVO Perfusion AB Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst